Search results
Results from the WOW.Com Content Network
For premium support please call: 800-290-4726 more ways to reach us
This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment ... market will grow at 11% a year through 2033 to $5.7 billion. ... market to grow by 13% a year to ...
Need help? Call us! 800-290-4726 Login / Join. Mail
Although no clinical development took place, Axovant held its IPO in June 2015 and raised $315 million, [4] the largest biotech IPO ever, [9] based on new phase IIB trials that were more promising. [10] The lock-up period against reselling stock was reduced to an unusually short 90 days for hedge funds that showed interest in the IPO. [11]
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The IPO market, particularly technology and fintech, has been rebuilding for a number of quarters, and we expect the market to open up more broadly next year across many core sectors, including ...
In September 2018, Titan Pharmaceuticals underwent an IPO wherein it raised $9.5 million in gross proceeds. [3] In the same month, ... History The company was founded ...
The IPO raised $604.3 million and eclipsed the $373 million raised by Allogene Therapeutics in October, which is the largest biotech since Axovant Sciences' $363 million IPO in 2015.